As part of the direct response to the Covid-19 pandemic, vaccination has always been the light at the end of the ever-lengthening tunnel. One of Osborne Clarke's clients, BioNTech, has been at forefront of vaccine development with the Pfizer-BioNTech Covid-19 vaccine being the first vaccine approved for use. The Osborne...

The Climate Change Committee (CCC) recently published (9 December 2020) a report detailing its recommendations for the Sixth Carbon Budget, which set out the steps the UK must take to achieve its goal of reaching net-zero greenhouse gas (GHG) emissions by 2050. One of the major recommendations from the report...

At the heart of the new European regulation laying down harmonised rules on artificial intelligence (AI) is a focus on high-risk AI systems and their stringent governance. However, despite this emphasis, there are crucial questions around AI products that qualify as "AI systems" but do not pose high-risk scenarios as...

We were delighted to welcome Rob Aitchison and Sam Gamble of Automated Markets at our recent OC.TV webinar event. They explained the coming risk to current forms of encryption from quantum computing, and what steps can be taken to understand and mitigate this risk. Osborne Clarke partner Charlie Wedin explained...

Even with the biggest supercomputers in the world, some problems remain too complex to unravel. This is not just an academic issue – many valuable commercial applications can be imagined but not delivered, or can currently only be delivered in a limited, constrained way. This includes: modelling complex molecules which...